Meijer Magnesium Citrate Laxative Recalled for Microbial Contamination
Meijer brand magnesium citrate laxative (10 fl oz) has been recalled nationwide due to microbial contamination of Lot 0557622. Consumers should discard or return the product.
What this means for you
Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.
Our severity reasoning: This is an FDA Class I recall, which is FDA's most serious classification indicating the product poses a risk of serious adverse health consequences. The hazard is microbial contamination of a non-sterile oral solution product.
Plain-English summary
Meijer brand magnesium citrate saline laxative (lemon flavor, 10 fl oz) manufactured by Vi-Jon, LLC has been recalled. The recall affects Lot 0557622 with expiration date 1/12/2024.
The recall was issued due to microbial contamination of the non-sterile oral solution product. The product was distributed nationwide in the United States as well as in Canada and Panama.
Consumers who have purchased this product should stop using it and either discard it or return it to the place of purchase for a refund. The affected product can be identified by NDC 41250-708-38 and UPC 7 13733 45945 7.
The recalled product
- Product
- meijer, magnesium citrate Saline Laxative, Oral Solution, (1.745 g/fl oz), Lemon Flavor, 10 FL OZ (296 mL), Dist. By Meijer Distribution, Inc. Grand Rapids, MI 49544; NDC 41250-708-38 UPC 7 13733 45945 7
- Manufacturer
- Vi-Jon, LLC
- Category
- Drug — Over-the-Counter Laxative
- Hazard
- microbial-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot# 0557622
- EXP 1/12/2024
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27